A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors. [PDF]
Cancer Chemother Pharmacol, 2011 Kulke MH +8 more
europepmc +1 more source
The relation of urinary estrogen metabolites with mammographic densities in premenopausal women. [PDF]
Cancer Epidemiol, 2012 Maskarinec G +4 more
europepmc +1 more source
Chemopreventive properties of 3,3'-diindolylmethane in breast cancer: evidence from experimental and human studies. [PDF]
Nutr Rev, 2016 Thomson CA, Ho E, Strom MB.
europepmc +1 more source
Urinary estrogen metabolites in women at high risk for breast cancer. [PDF]
Carcinogenesis, 2009 Im A +6 more
europepmc +1 more source
Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer. [PDF]
PLoS One, 2011 Rajoria S +6 more
europepmc +1 more source
Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer. [PDF]
Br J Cancer, 2011 Zeleniuch-Jacquotte A +16 more
europepmc +1 more source
Re: "A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer". [PDF]
Environ Health Perspect, 1998 Bradlow HL, Kabat GC.
europepmc +1 more source
Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular Metabolism. [PDF]
Circulation, 2016 Chen X +19 more
europepmc +1 more source
Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy. [PDF]
Horm Cancer, 2016 Oh H +21 more
europepmc +1 more source
Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis. [PDF]
J Exp Clin Cancer Res, 2009 Barba M +11 more
europepmc +1 more source